Albers Jeffrey W.
Director
6 filings on record here, covering SYRE, EME, DBI, BRC, KYMR. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-10
| Exercise | SYRE | Spyre Therapeutics, Inc. | $51,950 |
| Sell | SYRE | Spyre Therapeutics, Inc. | $522,350 |
| Sell | SYRE | Spyre Therapeutics, Inc. | $835,040 |
| Sell | SYRE | Spyre Therapeutics, Inc. | $1,046,800 |
| Exercise | SYRE | Spyre Therapeutics, Inc. | |
CORPORATEFiled 2026-08-03
| Award | EME | EMCOR Group, Inc. | |
CORPORATEFiled 2026-07-10
| Award | DBI | Designer Brands Inc. | |
CORPORATEFiled 2026-07-06
| Award | BRC | BRADY CORP | $24,548 |
CORPORATEFiled 2026-06-25
| Award | KYMR | Kymera Therapeutics, Inc. | |
CORPORATEFiled 2026-06-22
| Award | DBI | Designer Brands Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.